Developer of regenerative biologics treatment designed for tissue healing and organ restoration. The company integrates cell modification, high-yield exosome generation, molecular loading, and formula...

Healthcare
Paris, France
Founded 2019
19 employees
Website
Valuation
$27.6M
Market implied
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A

Get the full picture

Create a free account to unlock EVerZom's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required